SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 24, 2005
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as specified in its charter)
Delaware 1-14120 52-1611421
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
One Jake Brown Road, Old Bridge, New Jersey 08857
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 679-4000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 4.01. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On August 30, 2005, Blonder Tongue Laboratories, Inc. (the "Company") filed a
Current Report of Form 8-K to disclose the resignation of BDO Seidman, LLP as
the Company's independent registered public accounting firm.
Effective October 24, 2005, the Company engaged Marcum & Kliegman LLP as its
independent registered public accounting firm to review the Company's quarterly
results for the third quarter ending September 30, 2005 and to audit its
financial statements as of and for the year ended December 31, 2005. The
engagement of Marcum & Kliegman was unanimously approved by the Audit Committee
of the Board of Directors on October 13, 2005.
During the Company's two most recent fiscal years ended December 31, 2003 and
2004, and for the interim period through June 30, 2005, neither the Company nor
any person acting on its behalf has consulted with Marcum & Kliegman regarding:
(i) either the application of accounting principles to a specified transaction,
either completed or proposed; or the type of audit opinion that might be
rendered on the Company's financial statements, and either a written report was
provided to the Company or oral advice was provided that Marcum & Kliegman
concluded was an important factor considered by the Company in reaching a
decision as to the accounting, auditing or financial reporting issue; or (ii)
any matter that was the subject of a disagreement (as defined in Item 304
(a)(1)(iv) of Regulation S-K and the instructions to Item 304) or that
constituted a reportable event (as described in Item 304 (a)(1)(v) of Regulation
S-K) with respect to the Company's financial statements.
Forward Looking Statements
This report contains forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. These statements are neither
promises nor guarantees, are based upon assumptions and estimates that might not
be realized and are subject to risks and uncertainties that could cause actual
results to differ materially from those in the forward looking statements.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BLONDER TONGUE LABORATORIES, INC.
By: /s/ Eric Skolnik
Eric Skolnik
Senior Vice President and
Chief Financial Officer
Date: October 25, 2005
